Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Bio-Rad Laboratories's profit margin for the twelve months ending Jun 30, 2026 was 8.6%. For fiscal 2025 it was 29.4%, against -71.9% the year before. The highest annual figure on record is 149.8% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29.4% | +101.3 |
| FY2024 | Dec 31, 2024 | -71.9% | −48.0 |
| FY2023 | Dec 31, 2023 | -23.9% | +105.6 |
| FY2022 | Dec 31, 2022 | -129.5% | −275.0 |
| FY2021 | Dec 31, 2021 | 145.6% | −4.3 |
| FY2020 | Dec 31, 2020 | 149.8% | +73.8 |
| FY2019 | Dec 31, 2019 | 76.1% | +60.1 |
| FY2018 | Dec 31, 2018 | 16.0% | +10.3 |
| FY2017 | Dec 31, 2017 | 5.7% | +4.4 |
| FY2016 | Dec 31, 2016 | 1.3% | −4.2 |
| FY2015 | Dec 31, 2015 | 5.4% | +1.3 |
| FY2014 | Dec 31, 2014 | 4.1% | +0.4 |
| FY2013 | Dec 31, 2013 | 3.6% | −4.3 |
| FY2012 | Dec 31, 2012 | 8.0% | −0.6 |
| FY2011 | Dec 31, 2011 | 8.6% | −1.0 |
| FY2010 | Dec 31, 2010 | 9.6% | +1.5 |
| FY2009 | Dec 31, 2009 | 8.1% | +3.0 |
| FY2008 | Dec 31, 2008 | 5.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 57.1% | +8.3 |
| Q1 FY2026 | Mar 31, 2026 | -89.0% | −100.0 |
| Q4 FY2025 | Dec 31, 2025 | 103.9% | +211.1 |
| Q3 FY2025 | Sep 30, 2025 | -52.4% | −152.9 |
| Q2 FY2025 | Jun 30, 2025 | 48.8% | +387.9 |
| Q1 FY2025 | Mar 31, 2025 | 10.9% | −51.9 |
| Q4 FY2024 | Dec 31, 2024 | -107.2% | −158.6 |
| Q3 FY2024 | Sep 30, 2024 | 100.5% | +83.7 |
| Q2 FY2024 | Jun 30, 2024 | -339.2% | −168.5 |
| Q1 FY2024 | Mar 31, 2024 | 62.9% | +52.7 |
| Q4 FY2023 | Dec 31, 2023 | 51.3% | −62.0 |
| Q3 FY2023 | Sep 30, 2023 | 16.8% | +40.7 |
| Q2 FY2023 | Jun 30, 2023 | -170.7% | −36.8 |
| Q1 FY2023 | Mar 31, 2023 | 10.2% | +491.2 |
| Q4 FY2022 | Dec 31, 2022 | 113.3% | +327.9 |
| Q3 FY2022 | Sep 30, 2022 | -23.9% | −550.0 |
| Q2 FY2022 | Jun 30, 2022 | -133.9% | −261.9 |
| Q1 FY2022 | Mar 31, 2022 | -481.0% | −615.8 |
| Q4 FY2021 | Dec 31, 2021 | -214.5% | −320.8 |
| Q3 FY2021 | Sep 30, 2021 | 526.1% | +322.9 |
| Q2 FY2021 | Jun 30, 2021 | 128.1% | −51.9 |
| Q1 FY2021 | Mar 31, 2021 | 134.8% | +14.8 |
| Q4 FY2020 | Dec 31, 2020 | 106.3% | +17.6 |
| Q3 FY2020 | Sep 30, 2020 | 203.1% | +249.3 |
| Q2 FY2020 | Jun 30, 2020 | 180.0% | +75.4 |
| Q1 FY2020 | Mar 31, 2020 | 120.0% | −36.2 |
| Q4 FY2019 | Dec 31, 2019 | 88.6% | +222.9 |
| Q3 FY2019 | Sep 30, 2019 | -46.2% | −95.6 |
| Q2 FY2019 | Jun 30, 2019 | 104.6% | +58.0 |
| Q1 FY2019 | Mar 31, 2019 | 156.2% | +37.1 |
| Q4 FY2018 | Dec 31, 2018 | -134.3% | −147.6 |
| Q3 FY2018 | Sep 30, 2018 | 49.4% | +45.3 |
| Q2 FY2018 | Jun 30, 2018 | 46.5% | +45.5 |
| Q1 FY2018 | Mar 31, 2018 | 119.1% | +116.6 |
| Q4 FY2017 | Dec 31, 2017 | 13.3% | +16.6 |
| Q3 FY2017 | Sep 30, 2017 | 4.1% | +0.8 |
| Q2 FY2017 | Jun 30, 2017 | 1.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 2.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -3.3% | – |
| Q3 FY2016 | Sep 30, 2016 | 3.4% | – |